Physician profile
Danielle Austin
NPI 1437599362
$950.63
in general payments reported to CMS, 2019-2025
17 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $184 · 2021: $158 · 2023: $158 · 2024: $91.63 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $151.06 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $136.56 | 2019-2025 | |
| Therapeuticsmd, INC. | $124.35 | 2019-2021 | |
| Abbvie INC. | $102.38 | 2019-2021 | |
| Kedrion Biopharma, INC. | $85.31 | 2023 | Albuked, Rhogam Ultra-Filtered Plus, Gammaked |
| Exeltis, USA INC. | $66.67 | 2020-2025 | Slynd |
| Lupin INC. | $54.13 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $42.09 | 2025 | |
| Pfizer INC. | $39.35 | 2021-2024 | |
| Coopersurgical, INC. | $20.29 | 2025 | Paragard T 380a |
| Eagle Pharmaceuticals, INC. | $19.22 | 2023 | |
| Merck Sharp & Dohme LLC | $19.20 | 2024 | Gardasil 9, Gardasil |
| Agile Therapeutics, INC. | $18.95 | 2021 | |
| Seqirus USA INC | $18.83 | 2025 | Flucelvax |
| Hologic Sales and Service, LLC | $18.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.88 | 2019 | |
| Avion Pharmaceuticals | $16.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.